Atlas Trials

The Pharmacokinetics and Pharmacodynamics of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria

Clinical trial NCT04079257 · COMPLETED

Trial details

NCT number
NCT04079257
Sponsor
Radboud University Medical Center
Status
COMPLETED
Study type
OBSERVATIONAL
Paroxysmal Nocturnal HemoglobinuriaEculizumabPK-PD
Start date
2021-02-23
Primary completion
2022-07-01
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.